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Abstract
Background: Electrodermal activity (EDA) and other peripheral autonomic electrical parameters have been
used as indicators of emotional states, including depressive states and suicidal state. We aimed to review EDA
research systematically, focusing on EDA’s usefulness as a biomarker for depression and suicidal behaviour.
Methods: We searched MEDLINE, Scopus, Cochrane Library, and Web of Science databases, following PRISMA
guidelines. The initial screening of articles was based on titles and abstracts; then the full text was reviewed.
A preliminary synthesis of findings was developed using tables, thematic analysis and quality ratings.
Results: 1287 articles were screened and 77 relevant studies were identified and included in the systematic
review. The studies were fairly consistent in maintaining that hypoactive electrodermal response is an
established feature of patients affected by depression. There is also preliminary evidence that monitoring
EDA may help to differentiate the phases of mood disorders. A few studies provided evidence that EDA
can be used to differentiate acutely suicidal subjects from depressed patients who are not severely suicidal.
Although EDA has been shown to be a valid, sensitive marker of suicidal ideation, suicide attempts and
violent suicidal behaviour, it also seems to be influenced to some extent by antidepressant treatment.
Conclusions: Most of the studies summarised in this review are quite outdated and employed a variety of
designs and methods to evaluate EDA. This limits the generalisability of the results and makes it difficult to
draw clear conclusions about the role of EDA in real-world settings. Electrodermal hypoactivity seems to be
a reliable feature of depression and a valid marker of suicidal risk. Nevertheless, the potential utility of EDA
in diagnosis, prevention, and treatment planning for depression and suicidal behaviour, should be
thoroughly studied.
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Background
Rationale
Biological abnormalities may be risk factors for de-
pression, suicidal behaviour or completed suicide; a
recent review has identified the following major
categories of potential biological predictors of suicide
attempt behaviour: (1) results of structural and func-
tional brain imaging and (2) biochemical and genomic
findings relating to the major neurotransmitters
(serotonin, catecholamines, GABA and glutamate), the
hypothalamic pituitary adrenal (HPA) axis, the inflam-
masome, lipids and neuroplasticity [1]. Nevertheless,
there is currently a lack of biomarkers for the psychi-
atric field, in particular for suicidal behaviour. The
prediction of suicidal risk and identification of sui-
cidal patients will only be possible when we have an
accurate picture of the interplay between biological
and psychosocial factors. The use of the autonomic
responses as markers of emotion, attention, decision-
making, motor preparation, anticipation of reward or
punishment and unconscious detection has grown
considerably since the 1980s [2]. The most basic indi-
cators of the state of the autonomic nervous system
are heart rate and electrodermal activity (EDA); the
former is influenced by the sympathetic and parasym-
pathetic systems, whereas the latter is under sympa-
thetic control only. Since a useful biomarker should
be measurable in a non-invasive manner [3], the
features of EDA suggest that its potential utility as a
biomarker warrants careful consideration.
EDA is now the preferred term for changes in the
electrical conductance of the skin, which depend on
the quantity of sweat secreted by eccrine sweat glands
in the hypodermis of the palmar and plantar regions
[4]. Sympathetic nervous activity and variations in the
sweating of the skin are regulated by environmental
temperature (thermoregulatory sweating) and by cen-
tral nervous activity related to affective and cognitive
states (palmar, mental or emotional sweating) [5, 6].
EDA has been used as an index of emotional stimula-
tion in several experimental studies [7].
EDA has a tonic and a phasic component. The
tonic component is related to the slower components
and background characteristics of the signal (skin
conductance level; SCL). The phasic components are
the faster-changing elements of the signal that can be
associated with a stimulus (skin conductance re-
sponse; SCR) or “spontaneous” or “nonspecific” (non-
specific skin conductance response; NS.SCR) [8, 9].
It has been hypothesised that the central compo-
nent of EDA originates in the left hemisphere, but
this lateralisation remains controversial [10]. EDA
may be modulated by two different pathways: ipsilat-
eral modulation within the limbic system, via the
hypothalamus and thermoregulatory pathways and, to
a lesser degree, contralateral modulation by the pre-
motor cortex and basal ganglia [8, 11, 12].
In subjects exposed to emotional stimuli the ampli-
tude of electrodermal response increases linearly with
perceived arousal [13–16], whilst repeated presenta-
tion of identical, non-significant stimuli elicits pro-
gressively smaller reactions, a phenomenon known as
habituation [8]. Individual trait differences in EDA
have been observed and labelled as EDA lability.
Some individuals show a high rate of nonspecific
EDA and slow habituation to specific stimuli (labile
individuals), whereas others show less non-specific
EDA and more rapid specific EDA habituation (stable
individuals) [16, 17]. EDA lability is influenced by
both genetic and environmental factors [18] and is
often considered dependent on trait anxiety at the in-
dividual level. It has also been proposed as an endo-
phenotype of individual disposition towards emotional
expression, self-control and inhibition of contrasting
impulses [19, 20]. EDA-labiles people may be
described as calm, deliberative, restrained, more good-
natured, cooperative, and responsible, whereas EDA--
stable people tend to be active, emotionally expres-
sive, animated, assertive, more irritable, more
antagonistic, more impulsive and more irresponsible
[21, 22]. Both depression and suicide have been ex-
tensively investigated from a physiological point of
view, and the extant research has consistently demon-
strated that depressed and suicidal patients show elec-
trodermal hypoactivity and can therefore be described
as EDA-stable [23–26].
To the best of our knowledge the first review of
EDA in depression was published by Straub et al. in
the early 1990s [25]. It acknowledged that electroder-
mal hypoactivity had been repeatedly associated with
affective disorders, but raised doubts about whether
EDA could be considered a marker of depression,
pointing to conflicting results and differences in la-
boratory conditions and suggesting that the impact of
person-situation-environment dynamics on EDA had
been underestimated. A more recent review of gal-
vanic skin response (GSR) confirmed that patients
with mood disorders show low or flat EDA profiles,
but the authors pointed out several limitations in the
evidence, including that many of the EDA studies are
quite old and were conducted using outdated
methods and technology [26]. The Vahey & Becerra
review [26] anyway focused specifically on mood
disorders and yielded a smaller number of eligible
studies (41 vs. 77).
A summary of the current knowledge about the
relationships between EDA and depression and
between EDA and suicidal behaviour is timely, given
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the lack of recent comprehensive reviews [24] and the
recent publication of the study protocol for a multi-
centre, naturalistic, clinical study of electrodermal
orienting reactivity in a large sample of adult de-
pressed patients [27].
Objectives
Our objective was to carry out a systematic review of
studies investigating:
1. The association between EDA and depression
(research comparing depressed patients and
controls, depression subgroups, depressed patients
and other psychiatric patients, elicitation methods
and EDA, EDA and hormones, EDA and
antidepressants and other studies of EDA
characteristics).
2. The association between EDA and suicidal
behaviour (including research on suicidal risk,
suicidal ideation only, completed/attempted
suicide, violent/non-violent suicidal behaviour,
impulsive/non-impulsive suicidal behaviour and
suicide prevention) in depressed patients.
Methods
Selection of studies
The inclusion criteria were the following:
 EDA was measured.
 Design: randomised controlled trial (RCTs), quasi-
experimental (e.g. non-randomised controlled
studies and before-and-after studies), observational
or meta-analytical.
 Participants of any age or gender in a community or
clinical setting.
 The following types of study were eligible for
inclusion:
– studies involving participants with a primary
diagnosis of mood disorder (unipolar depression,
bipolar disorder, dysthymia, cyclothymia) who
were in a depressive phase;
– studies investigating the effects of an
antidepressant compound on EDA;
– studies involving participants with suicidal
ideation or suicidal behaviour (suicide attempts,
completed suicide).
Exclusion criteria were:
 Primary focus on psychiatric disorders other than
mood disorders.
 Investigation of the effects of EDA on medication
other than antidepressants.
 Case report, letter to the editor, conference paper,
dissertation, personal opinion or commentary.
 Papers not written in English.
Data sources and search strategy
We carried out an electronic literature search to
identify relevant studies. PubMed, Scopus, Cochrane
Library and Web of Science were searched from the
inception of the databases up to 12th April 2017.
The search strings used in each search engine are
reported in the Appendix 1. Articles were selected in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
diagram [28, 29]. The selection was done by three
reviewers (M.S., M.I., V.C.) who independently se-
lected titles, abstracts and full-text publications ac-
cording to the inclusion and exclusion criteria
described above. In the first stage of the selection
process titles were screened to exclude those that
were clearly not relevant to the review and then
each reviewer read the abstract and full text of the
remain articles and selected the relevant ones.
Disagreements between reviewers were resolved
through group discussion.
The following information was extracted from all
publications: country, design, characteristics of study
participants (number of subjects, diagnosis, mean age,
% women), EDA variables and summary of main
study findings. Regrettably, availability of information
on several issues - sample and diagnosis; study design
and protocol; type of EDA assessment; type of data
presented in the results etc. - was very uneven and
this meant that neither meta-analysis nor quantitative
synthesis was possible, nor was it possible to adhere
completely to the “Guidance on the conduct of narra-
tive synthesis in systematic reviews”; nonetheless the
guidance on data analysis and presentation was
followed as closely as possible [30]. Study quality was
appraised, where applicable, using the Newcastle-
Ottawa Scale (NOS) [31].
Results
The electronic searches identified 1278 studies; once
duplicates removed 823 records remained of which
606 were excluded because the title clearly had no
relevance to the review; 109 records were excluded
based on the Abstract; a further 68 studies were
excluded because they were not written in English
and 41 studies because the full text was not available.
We assessed the full text of 108 articles and excluded
31 studies at this stage. The main reasons for exclu-
sion were: study population did not match inclusion
criteria (no primary clinical diagnosis of depression),
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focus on psychophysiological variables other than
EDA (e.g. heart rate), basic, non-clinical research on
EDA and wrong type of publication (conference ses-
sion; letter to the editor; case report). Seventy-seven
studies met all the inclusion criteria and were in-
cluded in this review. The selection process is repre-
sented in Fig. 1.
Summaries of all the studies are presented in
Tables 1 and 2 (EDA and depression) and 2 (EDA
and suicidal behaviour).
Association between EDA and depression
Although low EDA in depressed patients was first de-
scribed in 1890 [32], interest in this physiological
variable as a marker of depressive disorders occurred
mainly between the late 1970s and the 1990s.
The studies included in this section are very varied,
both regarding sample and EDA variables. For clarity
they have been grouped under the following headings:
Depressed patients vs. controls; Depression subgroups;
Depressed patients vs. other psychiatric patients;
Elicitation methods and EDA; Other studies of EDA
characteristics; EDA and hormones; EDA and
antidepressants.
Depressed patients vs. controls
Nine studies, with a NOS score ranging from 2 (2
studies) to 5 (3 studies), mean NOS score 3.8, re-
ported lower SCL, increased SCR latency and lower
SCR amplitude in depressed subjects compared with
healthy controls [33–41]. Thorell et al. reported a
lower level of EDA in depressed patients than in
healthy subjects, reflected in lower central values
for SCL, SCR amplitude, SCR rate and an index of
non-response during neutral tone stimulation [42].
The overall efficiency of SCR as a means of
discriminating between depressed and healthy subjects
has been estimated to be about 80% [43]. It has also
Records after duplicates removed
(n=823)
Records identified through database 
searching
(n=1278)
Records screened 
(n=823)
Full-text articles assessed for eligibility
(n=108)
Studies included in qualitative 
synthesis
(n=77)
Records excluded
(n=715)
Full-text articlesexcluded
(n=31)
Fig. 1 PRISMA Flowchart
Sarchiapone et al. BMC Psychiatry  (2018) 18:22 Page 4 of 27
Table 1 Summary of selected studies – Electrodermal activity (EDA) and suicidal behavior
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY DESIGN
(QUALITY1)
Crowell et al. (USA,
2005)
− 23 parasuicidal adolescent girls,
age 14–18,
− 23 age-matched controls.
EDA recordings during the last
minute of a 10-min resting baseline
and for 10 min of recovery
following the end of a sad movie.
No significant differences on
measures of EDR between
parasuicidal girls and healthy
controls.
Case-control(3)
Edman et al. (1986) 35 drug-free, suicidal inpatients
(mean age 41 years; 63% females):
− 24 inpatients after a suicide
attempt;
− 11 patients with suicidal ideation.
SCL and habituation of the SCR. No differences in the SCL.
Tendency to lower figures in
NS.SCR in patients who used
violent suicide methods.
All violent attempters (at baseline
and follow-up) were fast
habituators.
Lowest frequency of fast
habituators in patients with
suicidal ideation.
Cross-sectional
Jandl et al.
(Germany, 2009)
MDD inpatients divided in 3
groups:
− 16 with history of ‘hard
attempted suicide’ (e.g., hanging,
stabbing) (47.3±11.9 years; 56%
females);
− 16 with a history of ‘soft
attempted suicide’ (e.g.
poisoning) (49.8±8 years; 69%
females);
− 18 no attempted suicide (47.9
±11.6 years; 67% females).
NS.SCR frequency, SCR amplitude
and EDA Habituation
Rate measured during an auditory
habituation paradigm.
Significantly lower EDA
habituation rate in both suicide
attempters groups.
No difference among the 3
groups in SCR amplitude or
NS.SCR frequency.
Women showed faster
habituation.
Cross sectional
Keller et al.
(Germany, 1991)
− 23 patients with suicide attempt
divided into violent and non-
violent method (violent, N=14,
41.4±9.5 years, 64% females; non-
violent, N= 9, 37.2±9.7 years,
66.6% females).
− Age and sex matched groups
(non-suicidal depressed patients/
patients with suicidal thoughts.
Number of stimuli until habituation,
nonspecific SC reactions, height of
first amplitude and SCL measured
during an habituation experiment.
All patients who had used a
violent method and patients who
committed suicide in the year
following the experiment were
fast habituators.
No difference in EDA between
non-suicidal patients, those with
suicidal thoughts or suicide
attempts.
Case-control
(4)
Sarchiapone et al.
(Europe, 2017)
-1573 patients with a primary
clinical diagnosis of depression,
either currently depressed or in
remission.
− ElectroDermal Orienting
Reactivity (EDOR Test)
It is hypothesized that the EDOR
Test will identify electrodermal
hyporeactive depressed patients
with a high suicidal proneness.
Patients who reveal strong death
intent are expected to be
hyporeactive at the EDOR test, in
most cases; non-hyporeactive
patients are expected to have
suicide attempts with strong
death intent in a minority of
cases.
Multicentric/
Study protocol
Spiegel (US, 1969) Inpatients including:
- 16 controls with no history of
suicide threats or attempts and
denying current suicidal thoughts;
- 15 inpatients with suicide threats
or preoccupations but no history
of attempts;
- 13 attempters with a history of
one or more suicide attempts.
GSR
First two sessions: word association.
4 days later, a series of words at
irregular intervals, recording skin
resistance changes.
Relatively low reactivity of
threateners might be a function
of depression.
Threateners were the least
reactive in terms of GSR to the
word “suicide”
Significant positive association
between magnitude of GSR and
intensity of affective meaning
assigned to the concept “suicide”
in all patients.
Crossover
Thorell (Sweden,
1987)
Thorell et al. (1987a)
Thorell et al. (1987b)
− 59 in- and out-patients with
major depressive episode and
dysthymic disorders (42±13.2
years; 54% females);
SCL at the onset of the first
stimulus, mean SC fluctuation rate
(SCFr) per minute, SCR magnitude
(SCRm) to the first stimulus, SCR
Significantly lower central SCL,
SCRm, SCRr, and SCRi, but not
SCFr and habituation values in
patients than in controls.
Case-control
(5)
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Table 1 Summary of selected studies – Electrodermal activity (EDA) and suicidal behavior (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY DESIGN
(QUALITY1)
− 59 mentally and somatically
healthy subjects (42.4±13.3 years;
54% females)
rate (SCRr), and index of SC
nonresponding (SCRi).
Considering medications, no
statistically significant difference in
any EDA variable.
No significant difference in any
EDA variable among dysthymic
disorder vs major depressive
episode and melancholic vs non-
melancholic major depressive
episode.
Patients with endogenous
depression had significantly lower
SCL, SCRr, and SCRi.
Patients with a high level of
inhibition showed significantly
lower SCL and SCRi.
Suicidal behavior related to low
electrodermal responsivity (EDR)
and low stimulus-unrelated phasic
activity, but unrelated to tonic
EDA.
Extreme hyporesponsivity in the
suicide attempters was observed
irrespective of whether the
attempt had been made
previously or during the current
depression.
Thorell et al. (2009) − 279 depressed patients
− 59 healthy subjects
Habituation of the
electrodermal response
Sensitivity 96.6% and specificity
92.9% of electrodermal
hyporeactivity for suicide and
83.3% and 92.7%, respectively, for
suicide and⁄or violent attempts
Meta-analysis
Thorell et al.
(Germany, 2013)2
783 depressive patients (126 bipolar
patients; 539 unipolar patients; 118
with other diagnoses) (42.9±11.5;
58% females):
− 32 violent suicide;
− 4 nonviolent suicide;
− 84 violent suicide attempt;
− 103 nonviolent suicide attempt;
− 560 other or no suicidal behavior.
Habituation of electrodermal
responses measured during an
auditory habituation paradigm.
Prevalence of electrodermal
hyporeactivity was high and
highest (80%) among bipolar
patients and was independent of
severity of depression, trait
anxiety, gender and age.
Sensitivity and specificity for
suicide, and for suicide and
violent suicide attempt were
83%, 98% and 74%, 88%,
respectively.
Hyporeactivity was stable, while
reactivity changed into
hyporeactivity in a later depressive
episode.
Cohort
(7)
Wolfersdorf et al.
(Germany, 1996)
− 11 patients with personality
disorders who attempted suicide
(23±4 years; 100% females);
− Depressed non-suicidal patients
(100% females);
− Depressed suicide attempters
(100% females);
− Schizophrenic non-suicidal
patients (100% females);
− Schizophrenic suicide attempters
(100% females).
SCL, number of NS.SCR, habituation
of the SCR
Significant differences in EDA
values between women with
personality disorders who
attempted suicide and non-
suicidal women suffering from
depression.
No difference between personality
disorder and depressive patients
who attempted suicide .
No significant differences in EDA
values in a habituation study
between personality disorder
patients and schizophrenic
women with or without histories
of suicide attempts.
Cross-sectional
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been reported that depressed patients show marginally
faster habituation of the skin resistance orienting re-
sponse than healthy controls [44, 45], although one
study [35] with a lower NOS score than the others (2
vs. 3 and 5) did not find this.
Some researchers looked at age- and gender-related EDA
variability. In adolescents [46] the results were consistent
with the notion that EDA is lower in major depressive dis-
order (MDD) patients than in control subjects. In contrast
SCL was similar in patients with dementia, depressed pa-
tients (mean age 75.9 ± 7 years) and healthy controls, prob-
ably due to a decline in the number of active sweat glands
and sweat production in the elderly. As far as gender is
concerned, SCLs were lower in women than in men in both
depressed patients and healthy controls [47].
A study of GSRfound that patients were hypore-
sponsive because of depressive inhibition in an ex-
perimental condition, but failed to find any difference
in GSR variables between patients and controls in
two rest periods and in a no-response experimental
condition [48].
Unlike most studies in this field Lapierre and
Butter reported a higher SCL and higher basal skin
resistance in depressed patients than in controls. The
amplitude of SCR and number of non-specific SCRs
were similar in depressed patients and controls [49].
Other studies reported higher SCLs in depressed sub-
jects than in healthy controls [50, 51] and psychiatric
controls [50]. A couple of studies [52, 53] failed to
find any difference between depressed patients and
healthy controls with respect to SCL [52] and SCR
[53] variables.
It should be noted that the Lapierre and Butter
study scored 0 on the NOS because of the lack of in-
formation about the study design, whereas the other
studies [50–52] described above had higher NOS
scores (5,4, and 4, respectively).
Briefly, lower EDA, especially lower SCL and SCR,
in depressed patients than in healthy controls was
the most consistently reported result.
Depression subgroups
It has been suggested that in depressed patients level
of EDA may be a function of the type of depression.
A recent, cross-sectional study offered preliminary
evidence that EDA levels may differentiate the phases
(depressive vs. mixed vs. euthymic) of bipolar
disorder [54].
Lower EDA levels were found in patients with psy-
chomotor retardation or symptoms of inhibition than
in agitated depressed patients ([55, 56, 58], mean
NOS score 4.3; [57, 59] cross-sectional studies), ex-
cept for the study by Lapierre and Butter, which was
the least robust in terms of NOS score [49; NOS
score 0]. Patients classified as suffering from “psych-
otic” (rather than “neurotic”) [60] and “endogenous”
(rather than “non-endogenous”) [61, 62] depression
had lower EDA levels, although this finding was not
consistent across all studies. Moreover, the published
research on this issue [40, 58, 59, 63] is highly het-
erogeneous with respect to NOS score (2, 5, not
applicable, and 1, respectively).
The absence of a SCR was observed in depressed
patients with predominance of anxiety symptoms [40].
Table 1 Summary of selected studies – Electrodermal activity (EDA) and suicidal behavior (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY DESIGN
(QUALITY1)
Wolfersdorf et al.
(Germany, 1999)
− 30 depressed violent suicide
completers (mean age 43.8 years;
57% females);
− Age and sex matched non-
suicidal depressed patients;
− Age and sex matched depressed
patients with suicidal ideations;
− Age and sex matched depressed
patients with suicide attempts.
Number of stimuli up to
habituation (habituation score, HS),
SCL and amplitude of SCR after the
first stimulus measured during a
habituation experiment using
auditory stimuli.
Depressed patients who died by
suicide showed significantly lower
HS, first amplitude of the SCR and
SCL than non-suicidal depressed
patients.
Suicides showed a significant
lower HS than non-suicidal
patients or depressive patients
with suicidal ideation.
No significant difference between
suicide and suicide attempters
groups.
Case-control
(5)
Legend:
1The “Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control and cohort studies” was used to evaluate the case-control (scores 0-10) and cohort
studies (scores 0-12)
2The sample comprises patients treated on the Depression Ward of the Centre for Psychiatry, Weissenau in southern Germany between 1985 and 2002. The
studies of Keller et al. (1991), Wolfersdorf et al. (1996) and Wolfersdorf et al. (1999) were conducted in the same centre
EDA = Electrodermal Activity; EDOR = ElectroDermal Orienting Response; HS = Habituation Score; MDD = Major Depressive Disorder; NS.SCR = Nonspecific Skin
Conductance Response; SCL = Skin Conductance Level; SCF = Skin Conductance Fluctuation; SCR = Skin Conductance Response
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Table 2 Summary of selected studies – Association between EDA and depression
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
Barg et al. (Germany,
1996)
− 16 depressed patients (36.1±1.9 years;
50% females), no medication;
− 16 depressed patients (45.8±10.2 years;
50% females) treated with paroxetine;
− 16 depressed patients (45.4±9.9 years;
50% females) treated with imipramine.
SCL, non-specific SCR, SCR Patients treated with
imipramine showed a
higher heart rate and
lower EDA than the other
two groups.
Case-Control
(5)
Bernstein et al.
(US, 1988)
− 50 schizophrenic patients
(34.8±9.5; 30% females);
− 50 depressive patients
(32.5±9.7 years; 66% females);
− 50 controls
(27.3±7.6 years; 58% females).
SCR recorded during
auditory stimuli
presentation.
A subsample of each
group was told they
needed do nothing
during tone presentations
(habituation series); other
subsamples had to press a
pedal for each designated
target signal, ignoring all
nontarget tones.
No differences between
hands in SCR for any
diagnostic group
Compared to normal
controls, schizophrenic
patients showed higher
nonresponding in the
habituation series, but no
difference when target
tones were presented.
Depressives were equally
nonresponsive during the
habituation series, but
they did not show a
decrease in SCR
nonresponding to the
target tone.
Case-control
(4)
Bernstein et al.
(US, 1995)
− 69 schizophrenic patients
(34.9±8.5 years; 42% females);
− 45 mood disorder patients
(36.6±10.1 years; 62% females);
− 67 normal controls
(31.2±10.1 years; 49% females).
SCR recorded during
exposure to tones.
Schizophrenic and
depressed patients were
significantly more often
classified as non-
responders.
The proportion of non-
responders did not vary
with neuroleptic or
antidepressant medication.
Case-control
(4)
Bob et al. (2011) − 44 unipolar depressed outpatients,
(37.06±8.72);
− 35 healthy controls
(35.12±8.10; 57% females).
EDA measured bilaterally. Absence of differences
between EDA in relapse
and in remissions as well
as between
pharmacotherapy
response and EDA.
Case-control
(4)
Bonnet et al.
(France, 2004)
− 9 non-depressed
Chronic Low Back Pain (CLBP)
patients, (43 years; 55% females);
− 9 depressed CLBP patients,
(46.1 years; 55% females);
− 9 depressed controls free of pain
(DCs), (44.1 years; 55% females);
− 9 healthy controls free of pain
and depression, (45.3 years; 55% females).
EDA recorded during a 3-
min rest period and
during a subsequent
stimulation period. Stimuli
were 3 identical pure
tones.
Non-depressed patients
presented an increased
EDA, especially a higher
frequency of non-specific
fluctuations, than the 3
other groups.
SCL was lower in the 2
groups of depressed
participants than in the
healthy control group.
Case-control
(4)
Brankovic (Serbia, 2008) − 57 patients with major depressive
disorder and currently in depressive
episode (43.1±10.9 years; 56% females);
− 52 healthy controls (39.8±8.1 years;
60% females).
5 parameters of the SCR
recorded when reading
emotional eliciting stories.
Initial SCR was larger in
controls than depressed
patients.
Positive feedback loop
was greater in depressed
patients than controls.
Negative feedback loop
was stronger in depressed
patients than controls.
Length of time needed for
the magnitude of SCRs to
decrease to half of the
original response
magnitude was longer in
Case-control
(3)
Sarchiapone et al. BMC Psychiatry  (2018) 18:22 Page 8 of 27
Table 2 Summary of selected studies – Association between EDA and depression (Continued)
AUTHORS (COUNTRY
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MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
depressed patients than
controls.
Breyer-Pfaff et al. (1982) 37 patients with primary depressive
disorders (22 endogenous and
15 non endogenous) (81% females)
treated with amitriptyline.
SCLs, SF, habituation and
amplitude of the SCR
recorded during the
exposure to tones and
during active and passive
situations.
Measures repeated on the
day before treatment
began and again after 14
and 28 days of treatment.
Compared to baseline
levels, EDA state at day 14
can be considered
inhibited and labile (larger
phasic and tonic reaction
amplitudes).
After 4 weeks of
treatment, lability had
returned to baseline, but
inhibition was unchanged.
No significant correlation
between EDA measures
and plasma drug levels.
Case-series
Byrne (Australia, 1975) − 18 acute depressive inpatients
(20-60 years; 50% females):
− 10 “neurotic depressive”;
− 8 “psychotic depressive”;
− 11 normal controls
(24-45 years; 45% females).
SCR amplitude, NS.SCR,
habituation rate.
Higher mean SCR, higher
frequency of NS.SCRs, and
slower skin response
habituation rata in the
neurotic depressive
sample. Higher mean SCR
amplitude in the control
sample.
No significant difference
between skin response
habituation rates of either
the control and neurotic
depressive, or control and
psychotic depressive
samples.
Case-control
(1)
Carney et al. (US, 1981) − 15 inpatients with primary affective
disorder (32±6.9 years; 100% females)
− 15 age-and race-matched controls
(31.5±7.5; 100% females)
SCL Significantly lower SCL in
depressed subjects.
No significant correlation
between SCL and
measures of anxiety or
depression for patients
with primary affective
disorder.
Significant correlations
between a measure of
depression and SCL in
normal controls.
Case-control
(5)
Dawson et al.
(US, 1977)
Dawson et al. (1985)
− 20 hospitalized depressed patients
(63.8±7.8 years; 80% females);
− 20 non-depressed controls
(62.2±7.6 years; 80% females).
SCL and SCR recorded at
rest and during a variety
of tasks before and after a
series of electroconvulsive
shock treatments (ECTs)
Depressed patients,
compared to non-
depressed controls during
the pre-ECT test, exhibited
lower SCLs, smaller phasic
SCRs with longer latencies.
Little EDA changes
following ECT.
Overall efficiency of SCL
was of 70% and of SCR
was 80%.
Case-control
(4)
Donat & McCollough
(US, 1983)
− 10 chronically depressed subjects
(18-25 years; 100% females);
− 10 controls (18-25 years; 100% females).
SCL SCL correctly identified 9
of the 10 depressed group
subjects and 7 of the 10
control group members
under resting conditions.
No difference between
depressed subjects and
controls under conditions
of laboratory stress and of
imaginal-role stress.
Case-control
(4)
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MEASURES MAIN STUDY FINDINGS STUDY
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SCL reliably identified
group membership, with
lower levels in the
depressed group.
Falkenberg et al.
(Germany, 2012)
− 16 patients with MDD
(37±15 years; 50% females);
− 16 healthy controls
(35±14 years; 50% females).
SCR recorded during
standardized mood
induction using happy
and neutral pictures and
funny and neutral
cartoons.
MDD patients had higher
SCRs in the cartoon
condition than controls.
Women revealed lower
overall SCRs compared to
men.
Case-control
(5)
Fraguas et al.
(US, 2007)
8 unmedicated patients diagnosed
with MDD (35±12 years; 62,5% females)
treated with fluoxetine 20 mg per day
for 8 weeks.
SCL and SCR measured at
basal condition and
during four induced
emotional states: happy,
angry, sad and neutral.
Significant positive
correlations between the
percentage reduction in
depression scores and
increases in SCR only
during the neutral
emotion condition.
Case-series
Giedke et al. (Germany,
1980)
− 18 patients with primary depression
(15 unipolar, 3 bipolar) (46.2±13.1 years;
83% females);
− 27 age-matched healthy controls
(45.1±15.4 years; 70.4% females).
GSR/SRR (Skin Resistance
Responses).
Response condition:
participants were asked to
react to the second of
two identical tone stimuli.
In the experimental
response condition
controls increased their
number and amplitude of
SRRs to tone-stimuli more
than patients.
No significant correlation
between GSR and both
self-rated and physician-
rated psychopathology.
Case-control
(5)
Giedke & Heimann
(1987)
− 59 drug free patients with primary
MDD (47±11 years; 69% females)
assigned to a double-blind treatment
with amitriptyline or oxaprotiline;
− 30 healthy controls matched for age and sex.
SR and habituation of SR
orienting response.
Patients with primary
MDD exhibited
significantly fewer
spontaneous fluctuations
of SR and a faster
habituation rate of SR
orienting response.
SR level did not differ
between groups.
Most patient/control
differences remained
unaffected irrespective of
the drug applied.
Case-control
+ RCT
(5)
Greco et al. (Italy, 2014) − 10 patients affected by bipolar
disorder I or II;
− 10 healthy subjects (20-32 years;
50% females).
Tonic and phasic features
of EDA measured during
an emotional elicitation
protocol.
Phasic features well
discriminated among
depression, mixed state,
and euthymia.
Mixed-state shows a
strong tonic hypoactivity
compared to euthymic
state.
Healthy subjects showed
no statistical difference on
each of the EDA feature
patterns.
Cross-
sectional
Hattangadi et al.
(Canada, 1968)
- 263 psychiatric inpatients, including
51 depressed patients (27 neurotic
and 24 psychotic depression);
- 58 healthy controls.
GSR Patients responded less
than controls to the
indifferent stimuli. No
significant difference in
response frequency
between patient
categories.
No significant difference in
latency, either between
normal subjects and
Case-control
(4)
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MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
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patients, or between any
two diagnostic categories.
All psychiatric patients in
all categories gave lower
amplitude responses than
the normal group.
No significant difference
between medicated and
non-medicated patients in
any diagnostic group as
far as GSR frequency and
latency.
Patients receiving
antidepressant medication
had higher amplitudes
than those receiving anti-
psychotic medications.
Have et al. (Iceland,
1991)
− 21 patients with Alzheimer dementia
(80.6 ± 9.8 years);
− patients with depression (75.9 ± 7 years);
− 19 healthy volunteers (79 ± 11.4 years).
SCL No difference in SCL
among patients' groups.
Very low SCL in the overall
sample, likely due to a
decline in the number of
active sweat glands in old
people and diminished
sweat production.
Case-control
(3)
Heimann (Germany,
1978)
− 95 depressive and depressive-anxious
patients;
− 18 of these 95 treated with amytriptylin
for 4 weeks;
− 27 of these 95 retested at a 1-year
follow-up.
SRR, SRL (Skin Resistance
Level).
Orienting reaction and
habituation tested after
two minutes of rest, with
a series of tones and of
flashes.
Assessment of changes in
the dimension of
activation after 14 and 28
days of treatment with
amytriptylin, and 1-year
follow up after the first
examination during a
depressive state.
Patients in the activated
and inhibited cluster
showed the smallest
changes at follow-up,
whereas all four patients
of the labile-activated
cluster change to another
group.
Preponderance of cases
with lower activation after
treatment with
amitriptylin.
Cross-
sectional
Iacono et al. (1983)
Iacono & Tuason (1983)
− 26 unipolar depressed patients
(37.8±12.7 years; 23% females);
− 24 with bipolar affective disorder
(36±12 years; 33% females);
− 46 healthy control patients
(35±11.9 years; 17.4% females).
SCL. The EDA of affective
disorder patients was
uniformly depressed
across all tasks and
conditions.
No consistent bilateral
asymmetries in EDA were
observed.
Case-control
(5)
Iacono et al. (1984)2 − 22 unipolar outpatients in remission
(41±12.7 years; 77% females);
− 22 bipolar outpatients in remission
(38.5±14.4 years; 68% females);
− 26 controls (41.3±12.2 years;
88% females).
SCLs and SCRs recorded
during blowing up a
balloon until it burst and
during the exposure to
tones, and eight familiar
sounds.
Compared to the control
subjects, the affective
disorder patients
(especially the unipolar
patients) responded
significantly less to the
balloon task, the highest
tones, and the familiar
sounds, had lower tonic
levels and a larger
proportion of them failed
to respond to the stimuli.
Several measures of EDA
displayed moderately high
one-year retest stability.
Case-control
(3)
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Ikeda et al. (Japan, 1982) 20 healthy volunteers (23.1 years;
0% females):
− Amitriptyline 30 mg/day, 3 times,
for 3 days;
− Nomifensine 100 mg/day, 2 times,
for 3 days;
− Placebo 3 times, for 3 days.
SCR recorded before the
experiment and 8 hours
after the final dose.
In the amitriptyline group,
the NS.SCR decreased.
In the nomifensine group,
NS.SCR tended to increase.
Kamenskaya & Mikhailova
(Russia, 1985)
− 50 manic-depressive patients in
the depressive phase prior to treatment
(20-45 years), divided into 3 groups
according to the nature of the principal
affect (anguish, anxiety, or apathy);
− 25 healthy individuals (20-45 years).
SCR in the background
and during the
presentation of indifferent
stimuli (opening the eyes,
light flashes) and in a
stress situation.
Depressed patients had an
increased latency and
lower amplitude of the
SCR than healthy subjects.
The absence of a SCR was
observed in 20% of
patients, more often with
a dominant anxiety affect.
Case-control
(2)
Lader & Wing (UK, 1969) − 35 inpatients with a primary diagnosis
of moderate or severe depression:
− 17 Predominantly agitated
(45.8 years; 59% females);
− 13 Predominantly retarded
(42.3 years; 69% females);
− 5 Uncomplicated depressives
(30.2 years);
− 35 age and sex matched controls.
SCLs, SCRs, NS.SCRs and
habituation rate recorded
during exposure to tones.
Agitated patients and
retarded patients had,
respectively, significantly
higher and lower mean
SCL than controls.
Agitated depressives had
the highest conductance
levels at the end of the
recording session than at
the start.
Healthy subjects were the
most reactive ones, and
habituated significantly
more rapidly than did the
agitated depressives.
Retarded patients gave a
significant lower number
of SCRs than agitated
patients.
The agitated patients had
significantly more and the
retarded patients had
significantly less
fluctuations than the
normal subjects.
Case-control
(4)
Lapierre & Butter
(Canada, 1978)
− 20 agitated depressed patients
(mean age 38 years and 2 months;
75% females);
− 20 retarded depressed patients
(mean age 37 years and 8 months;
70% females).
Spontaneous GSR was
monitored for 5 minutes.
The patient was then
given a series of 6
randomized visual and/or
auditory stimuli, and the
latency period for a EDA
response and the
magnitude of the
response was assessed.
Then: Maprotiline and
imipramine administration,
double-blind.
Measurement were
repeated after 3 hours, 4,
7, 14 and 28 days.
Basal skin resistance was
significantly lower for the
agitated depressive. The
GSR response was
consistently greater in the
agitated depressives than
in the retarded.
Gradual but nonsignificant
increase in skin resistance
and reduction in the
magnitude of the GSR
response as treatment
progressed in both drug
groups. Still the agitated
depressives maintained
more reactivity on this
parameter.
No major difference in
GSR was found between
imipramine and
maprotiline.
Double blind
controlled
study
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Lapierre & Butter
(Canada, 1980)
− 20 agitated depressed patients
(mean age 38 years; 75% females);
− 20 retarded depressed patients
(mean age 38 years; 70% females);
− 20 volunteer controls
(mean age 24 years; 75% females).
SCL and SCR recorded
prior, during and after
visual and auditory non-
signal sensory stimulations
and a reaction time
stimulation.
SCLs significantly higher
for both depressed
groups.
Depressed patients had
longer latency time of
onset of an EDA response
than in volunteers.
Case-control
(0)
Lemaire et al. (France,
2015)
− 45 bipolar outpatients:
− 15 remitted (41.67±10.19 years;
47% females);
− 15 moderately depressed
(43.4±11.65 years; 80% females);
− 15 moderately manic
(41.53±8.13 years; 73% females);
− 101 healthy controls
(43.86±11.96 years; 49% females).
Maximum SCR amplitude
recorded following the
presentation of affective
and neutral pictures
during passive viewing
and during experiential
suppression.
Negative and positive
pictures elicited SCRs of
similar maximum
amplitudes, greater than
those elicited by neutral
pictures.
The maximum SCR
amplitude was reduced
during experiential
suppression in all groups
but this effect was more
pronounced in depressed
patients.
Case-control
(4)
Levinson (US, 1991) − 36 schizophrenic patients
(31.4±6.9 years; 36% females);
− 17 patients schizoaffective disorder
(30.3±9 years; 59% females);
− 24 inpatients with MDD
(psychotic or nonpsychotic), or the
mainly affective subtype schizoaffective
disorder (36.9±12.4 years; 54% females);
− 25 control subjects
(30.6±9 years; 44% females).
SCL, SCR, NS.SCR, SC non-
response, habituation
score, reaction time
recorded during four
paradigms:
− a series of tones in a
no-task habituation
paradigm;
− a similar series of higher
tones;
− a series of tones with a
button-press (reaction
time) task;
− a loud white noise
stimulus (without task).
Schizoaffective subjects
were more likely to be
non-responders, and had
lower (faster) mean
habituation scores than
other groups.
Schizophrenic, depressed
and controls subjects had
similar mean habituation
scores and proportions of
non-responders.
Depressed subjects
showed some evidence of
autonomic hyperarousal
(higher tonic SC level,
trend toward more
NS.SCRs).
Case-control
(4)
Lewinsohn et. al
(USA,1973)
Two studies on the same sample composed by
− -12 depressed patients;
− -12 psychiatric control patients;
− -12 healthy control subjects.
Autonomic response (skin
resistance) to aversive
stimulation and
adaptation over repeated
presentations of the same
aversive situation.
In both studies, the
depressed group was
found to be more
responsive to the aversive
stimulus and the overall
SCL was highest for the
depressed subjects.
Case-control
(5)
Lindsey et al.
(US, 2011)
- 24 currently depressed Seasonal
Affective Disorder (SAD) participants
(41.58±11.72 years; 92% females);
- 24 demographically-matched
controls with no depression
(41.83±12.75; 92% females).
SCL, surface facial
electromyography and
self-reported emotional
responses to light- and
season-relevant stimuli
Task: 30 digital
photographs of 5 scenes
presented under 6
conditions (light intensity
– 2 conditions; seasonal
cues – 3 conditions).
SAD participants displayed
more frequent SCR,
greater SCR magnitude,
and more self-reported
depressed mood in
response to overcast
stimuli and lower SCR
magnitude, and less self-
reported depressed mood
in response to sunny
stimuli.
Case-control
(5)
Mardaga & Hansenne
(Belgium, 2009)
− 20 subjects with MDD
(22-59 years; 55% females);
− 20 healthy controls
(24-59 years; 55% females).
SCR recorded following
the presentation of
neutral, pleasant, and
unpleasant pictures.
Pleasant pictures elicited
more and larger responses
than unpleasant ones in
control but not in
depressed subjects.
Depressed subjects
showed generally faster
half-recovery times.
Case-control
(6)
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Mestanikova et al. (Slovak
Republic, 2015)
− 25 depressed adolescents
(14.6± 0.4 years; 52% females);
− 25 age/gender matched
healthy controls.
EDA measured in sitting
and supine position, at
rest.
EDA diminished in the
supine resting position in
MDD patients compared
to healthy controls.
Case-control
(4)
Miquel et al. (Spain,
1999)
− 27 depressed outpatients
(4 bipolar disorder in the depressive
cycle; 17 MDD; 5 depressive neurosis; 1
subject non-specified depressive disorder)
(34.63±10.05 years; 19; 70% females);
− 27 normal subjects (33.44±10.27 years;
63% females).
SCL and SCR recorded
during a series of tones.
Depressive patients
displayed lower basal SCLs
and lower conductance
amplitudes to the first
stimulus and to stimulus
change.
A trend towards
habituation was detected
in both groups, but
neither difference
between them, nor
differences in habituation
speed were found
between depressive and
healthy subjects.
Case-control
(2)
Mirkin & Coppen (1980 − 13 depressive inpatients
(58.6±1.9 years; 72% females).
− 15 normal controls
(54.2±1.7 years; 60% females).
SCL and SCR recorded
during exposure to tones.
Higher proportion of
electrodermal non-
responders in patients
than controls.
Endogenous depressive
patients had significantly
lower SCLs than either the
non-endogenous patients
or controls.
Case-control
(1)
Myslobodsky & Horesh
(Israel, 1971)
− 10 endogenous depressive patients
(51±6.79 years; 70% females);
− 9 reactive depression patients
(43±6.29 years; 89% females);
− 14 normal subjects
(48±17.59 years; 57% females).
EDA recorded at rest and
during three experimental
conditions: a visual-
imagery task, a verbal task,
a neutral tone habituation
sequence.
In endogenous depression
EDA was higher on the
left hand compared with
the right under all the
conditions studied.
In reactive depression EDA
was higher on the left side
during the verbal task and
tone habituation sequence
and on the right side in
the visual task.
Case-control
(3)
Nissen et al. (2010) − 23 patients with MDD;
35 healthy control matched
for sex, age, and IQ.
SCR recorded during the
presentation of
Conditioned (CS+) and
non-Conditioned (CS-)
Stimuli.
MDD patients responded
stronger to the CS+ than
to the CS-.
Case-control
(4)
Noble & Lader (UK, 1971) − 34 inpatients with a primary diagnosis
of depression (12 males, 44.3±13.6 years;
22 females, 35.7±11.4 years);
− Subgroups of 10 agitated and 10
retarded depression patients.
SCLs, SCRs, NS.SCRs
recorded at rest and
during mental arithmetic,
before and after ECT.
The stress of mental
arithmetic was associated
with increase in skin
conductance. The
difference between the
basal and stress recordings
(reactivity) was highly
significant. Reactivity was
reduced after ECT.
Low skin conductance
correlated significantly
with severity of
depression.
A reduction in NS.SCR
correlated with high
scores for depressed
mood and retardation.
Before ECT the agitated
patients had significantly
Cross-
sectional
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more fluctuations than the
retarded group.
No significant overall
change in EDA measures
after ECT.
O’Kearney & Parry
(Australia, 2014)
− 24 depressive episode (39.6±16.98 years;
67% females);
− 24 PTSD (31.7±16.49 years; 50% females);
− 24 healthy controls (35.8±15.73 years;
50% females).
SCR. PTSD showed higher SCR
during trauma recall
compared with recall of
other events and
compared with depressed
controls.
No significant difference in
reactivity between
depressed and non-
disordered participants.
Case-control
(4)
Pazderka-Robinson et al.
(2004)
− 43 patients with chronic fatigue
syndrome (46.3±9.6 years; 100% females);
− 25 depressed patients (35.3±10.5 years;
100% females);
− 44 controls (27.8±9.3; 100% females).
SCL and SCR recorded
during an orienting task.
SCLs were markedly lower
for the chronic fatigue
syndrome group, with no
difference between
controls and depressives.
Case-control
(4)
Perez-Reyes & Cochrane
(US, 1967)
− 108 neurotic depressed inpatients;
− 82 psychotic depressed inpatients;
− 69 healthy volunteers.
SCL and mean number of
SCRs per minute.
No difference in initial SCL
or SCR frequency, but
significant differences in
SCR susceptibility among
the three groups.
Case-control
(1)
Pruneti et al. (Italy, 2010) − Outpatients (38.4±9.7 years; 52% females)
with the following diagnoses:
− Generalized Anxiety Disorder (GAD, n = 24);
− Major Depression Episode (MDE, n = 14);
− Panic Disorder (PAD, n = 12);
− Obsessive-Compulsive Disorder (OCD, n = 10).
SCR registered in three
consecutive phases:
baseline (registration at
rest), stress presentation,
and recovery.
SCR mean values are
much higher for GAD and
PAD patients than for MDE
and OCD.
The amplitude of the SCR
was also significantly
different among groups.
Cross-
sectional
Rohde et. al (Germany,
2014)
− 43 currently depressed patients
(36.34±11.36 years; 60% female);
− 36 controls (32.19±12.26 years;
66% female);
− physiological data of 32 currently
depressed participants and 23 controls.
SCR, EMG corrugator
activity at baseline and
during a Mindful
Breathing Exercise.
Mindful episode: the
patient mindfully
observed his/her
breathing.
Drifted episode: the
patients had his/her mind
wandering, not focused
on the task.
SCR: no significant
differences were found
between currently
depressed patients and
controls.
In both groups, greater
SCRs recorded during
drifted episodes, while
weaker SCRs were elicited
within mindful episodes.
Case-control
(4)
Rottenberg et al. (2002,
USA)
− 71 depressed persons (mean age 33.4 years;
66% females);
− 33 non-depressed healthy controls
(mean age 32.3 years; 70% females).
SCL and SCR recorded at
baseline and after stimuli
(neutral film and cry-
inducing film).
During the sad film, non-
depressed criers had
greater number of SCR
than non-depressed non-
criers.
Non-depressed non-criers
exhibited significant
decreases in SCL from the
neutral to the sad film.
Depressed criers exhibited
significantly smaller
increases in SCL and SCR
rate to the sad film than
did non-depressed criers.
Case-control
(5)
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Schneider
(US, 1983)
− 10 depressed inpatients (9 with
unipolar and 1 with bipolar disorder)
(mean age 43.1 years; 0% females);
− 23 schizophrenic inpatients (13 who
underwent drug 'washout' and 10
who didn’t) (mean age 45.2 years;
0% females);
− 10 healthy controls (mean age
40.9 years; 0% females).
SCL, SCR and NS.SCR
recorded during exposure
to tones.
SCLs were higher in the
normal and schizophrenic
groups than in the other
two groups.
The depressives' mean
laterality index, unlike that
of the controls, reflected
lower SCLs and SCRs from
the right hand than from
the left.
The indices from the other
two patient groups did
not significantly differ
from controls’ ones.
The patient groups
generally had a lower
proportion of 'responders'
than did the health
controls group, a lower
number of SFs and a
lower SF amplitude.
Case-control
(2)
Schneider D. et al.
(Germany, 2012)
− 28 in- and out-patients with unipolar
MDD (age range 21–54 years; 43% females);
− 28 age- and education-matched
control participants.
Galvanic skin conductance
(GSC), galvanic skin
responses (GSR).
Stimuli: 96 short video-
clips conveying one of 4
emotion categories
(happy, sad, fear, disgust)
or no emotion (neutral).
Patients displayed more
GSRs than healthy controls
in all emotion categories.
In patients, the number of
GSRs did not differ
between emotion
categories, and neutral
video clips evoked less
GSRs than happy, sad,
fearful and disgusted clips.
Case-control
(4)
Siepmann et al.
(Germany, 2001)
12 healthy volunteers
(mean age 25 years; 0% females):
− Reboxetine 4 mg, twice a day, for 13 days;
− Placebo, twice a day, for 13 days.
SCL and SCR recorded
following a single deep
inspiration.
SCR was decreased after
multiple dosing with
reboxetine.
Crossover
Siepmann et al.
(Germany, 2003)
12 healthy volunteers
(mean age 34 years; 0% females):
− Sertraline 50 mg, once a day, for 14 days;
− Placebo, once a day, for 14 days.
SCL and SCR recorded
following a single deep
inspiration
Sertraline caused a
significant reduction of
SCL, whereas SCR was not
changed.
Crossover
Siepmann et al.
(Germany, 2004b)
12 healthy volunteers
(mean age 27 years; 0% females):
− Moclobemide 150 mg, twice a day,
for 14 days;
− Placebo, twice a day, for 14 days.
SCL and SCR recorded
following a single deep
inspiration
SCRs did not change after
treatment with
moclobemide.
Crossover
Siepmann et al.
(Germany, 2004a)
12 healthy volunteers (25±3 years; 0% females):
− Amitriptyline 25 mg, 3 times daily for 13 days;
− St. John’s wort extract, 3 times daily for 13 days;
− Placebo, 3 times daily for 13 days.
- SCR recorded following a
single deep inspiration.
St. John’s wort extract had
no effect on SCR.
SCR significantly decreased
during treatment with
amitriptyline at all time
points of measurement.
Crossover
Sigmon et al.
(USA, 2007)
-15 MDD patients, Recurrent, with
Seasonal Pattern (MDD-SAD;
80% females);
-15 MDD patients (MDD; 66.7% females);
-15 controls (80% females).
Mean age 38.93 years.
Baseline SCL recordings
obtained for a 5-min
baseline period and
average SCL collected
across the baseline period.
SCR at baseline and after
presentation of winter and
summer scenes were
recorded.
MDD-SAD patients
exhibited a greater
number of SCR and
greater SCR amplitude in
reaction to the winter
scenes, than individuals in
the MDD and control
groups.
Individuals in the control
and MDD groups did not
significantly differ on
frequency of SCR or
strength of SCR amplitude
Case-control
(5)
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Table 2 Summary of selected studies – Association between EDA and depression (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
in response to winter
scenes. Individuals in the
three groups did not
significantly differ on SCR
amplitude, in reaction to
the summer scenes.
Silva et al.
(Brazil, 2000)
-29 adult healthy volunteers
(86% females) received
- 100 mg Nefazodone (NF)
(mean age 25 years);
- 200 mg NF (mean age 26.6 years);
- placebo (mean age 24.9 years).
(Double-blind condition).
Test 1: (1) amplitude of
SCR - fluctuations that
occurred within 5 s from a
sound stimulus; (2)
number of spontaneous
fluctuations – those
occurring be
yond the above
mentioned 5-s window;
(3) SCL – average level of
conductance during the
intervals between
fluctuations.
Conditioned fear. NF
decreased the number of
spontaneous fluctuations
of skin conductance in a
dose-dependent way,
although the drug did not
affect the amplitude of the
SCR to the tone.
Crossover
Double-blind
Storrie et al.
(US, 1981)
− 10 inpatients with Primary Affective
Disorder, free from psychoactive
medications for at least 3 days prior
the initial testing (48±4 years; 0% females);
− 10 healthy subjects without history of
depressive dysfunction or psychosis
(49±5 years; 0% females).
SCL and SCR recorded
during Valsalva
maneuvers.
Measures repeated three
weeks after initiation of
therapy with tricyclic
antidepressants or
antipsychotic medication.
Laterality hypothesis not
confirmed.
Mean SCL and SCR
significantly higher in the
control group than in
depressed patients.
No significant difference in
SCL and SCR between
treated and untreated
patients.
Case-control
(5)
Thorell & D’Elia (Sweden,
1988)3
− 28 in- and out-patients with major
depressive episode and dysthymic
disorders (42.5; 50% females);
− 59 mentally and somatically healthy subjects.
SCL at the onset of the
first stimulus, mean SC
fluctuation rate (SCFr) per
minute, SCR magnitude
(SCRm) to the first
stimulus, the SCR rate
(SCRr), and the index of
SC nonresponding (SCRi).
Significantly higher EDA
during remission than
during depression
according to all 5 EDA
variables.
No significant difference in
EDA between patients in
remission and healthy
subjects.
Among suicide attempters,
EDA at follow-up did not
change significantly, but
was not significantly lower
than in healthy subjects.
However, SCRm and SCRi
in suicide attempters were
significantly lower at
follow-up than in the
healthy group.
The extremely
hyporesponsive patients,
including suicide
attempters, when in
remission, did not reach
the levels of the healthy
subjects except for SCFr.
The patient with recurrent
major depressive episodes
when in remission did not
reach the electrodermal
responsivity levels found
in the healthy subjects.
Case-control
(5)
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Table 2 Summary of selected studies – Association between EDA and depression (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
Thorell et al.
(1988, Sweden)
− 59 depressed patients;
− 59 healthy controls.
After 5 min without
stimulation,
37 tones were presented.
SCL at onset of
the first stimulus; stimulus-
unrelated SC fluctuation
rate (SCFr) during the
whole stimulation session
except for 10 s after onset
of each stimulus; SC
response magnitude
(SCRm) to the first
stimulus; SCR rate (SCRr);
index of SC
nonresponding (SCRi).
Cortisol in plasma and in
urine were dosed,
dexamethasone
suppression test (DST) was
performed.
No significant correlation
between EDA and cortisol
in patients’ plasma and
urine.
No relationship between
EDA and the outcome of
DST, neither any simple
relationship between EDA
and cortisol in plasma and
in urine.
Positive correlation
between SCL and morning
plasma cortisol and
negative correlations
between EDR and
nocturnal urinary cortisol
in the suicide attempters.
In the suicide attempters,
the already extremely low
EDR is additionally
suppressed with increased
nocturnal urinary cortisol
excretion while SCL, and
to some extent also EDR,
are elevated with
increased morning plasma
cortisol. This pattern is
opposite to that obtained
in the healthy subjects
and in the non-suicidal
patients for SCL and
plasma cortisol.
Case-control
(5)
Thorell et al. (Sweden,
1993)
− 50 depressive patients
(42.2±13.4 years; 52% females);
− 50 age and gender-matched
healthy subjects (42.6±13.5 years;
48% females).
Blood and urine for the
measurement of basal
hormone levels were
collected at 8
a.m., immediately followed
by clinical ratings and EDA
measurements.
Positive relationships
between SCL and basal
levels of thyroid hormones
in the healthy subjects
were absent or reversed in
the depressive patients.
No relationships between
electrodermal responsivity
and thyroid hormones in
depressive and healthy
subjects.
No significant difference
between drug-free
patients and patients
treated with
antidepressant
medications regarding the
EDA variables.
Case-control
(4)
Toone et al.
(UK, 1981)
− 22 schizophrenic patients
(mean age 35.8 years; 64% females);
− 11 unipolar depressed patients
(mean age 40.6 years; 73% females);
− 4 manic patients (mean age 38.7 years;
50% females);
− 12 anxiety state patients (mean age 30.1 years;
50% females);
− 22 healthy controls (mean age 36.7 in males
and 39.3 in females; 36% females).
SCLs, SCRs and SF
recorded at rest and
during 32 flashes.
No group showed a
distinctive pattern of
lateral asymmetry; the only
significant difference was
in the adaptation of SCL
during stimulation.
Among depressed males
the adaptation of SCL
during stimulation on the
left exceeded the right;
among depressed females
the trend was reversed.
The frequency of SF in
EDA was greater in the
Case-control
(6)
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Table 2 Summary of selected studies – Association between EDA and depression (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
anxiety state and
schizophrenic groups and
in those patients who
reported auditory
hallucinations during
recording.
Tsai et al.
(US, 2003)
− 12 Spanish-speaking latinas with major
depressive episode (28.28±7.45; 100% females);
− 10 non-depressed Spanish-speaking
latinas (28.28±7.45; 100% females).
SCL during sad and
amusing film clips of
human and animal
content.
Depressed Latinas
demonstrated less
electrodermal reactivity
across all the film clips
than non-depressed
Latinas.
Case-control
(4)
Ward et al.
(USA, 1983)
− 33 depressed patients
(mean age 42.58 years; 36% females);
− 71 healthy controls
(mean age 35.59 years; 46% females).
SCL was examined during
15 minutes during the first
week of hospitalization.
Healthy and depressed
women had significantly
lower SCLs than healthy
and depressed men;
subjects with recurrent
depression had
significantly lower SCLs
than subjects with a first
episode depression.
Significant positive
correlation between age
and SCL in the depressed
group but not in the
control group.
No significant SCL
differences between
medicated and
unmedicated patients.
No significant SCL
differences between
endogenous-
nonendogenous,
situational-non-situational,
primary-secondary, or DST
suppressor-DST non-
suppressor depression.
SCL proved a very
sensitive and specific test
for distinguishing non-
geriatric unipolar
depressed adults from
physically healthy normal
controls.
Case-control
(3)
Ward & Doerr
(1986)
− 37 in- and out- patients with major
affective disorder (mean age 35.3 years;
59% females);
− 71 controls (control group 1)
(mean age 35.5 years; 46% females);
− 334 "stressed" normal controls (control group 2)
who were first parents of newborns
(mean age 28.7 years; 51% females).
Resting SCL. Lowest SCLs in the
depression group. No
difference between the
two control groups.
For women, SCL less than
3.0 micronho/cm2 yielded
a sensitivity of 95% and a
specificity of 91% for
Control Group 1. For
males, a criterion of SCL
less than 4.8 yielded a
sensitivity of 93% and a
specificity of 89% for
Control Group 1.
No significant difference in
SCL between drug-free
and medicated patients.
SCL was abnormally low in
all depression subtypes.
Case-control
(3)
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In brief, patients classified as suffering from “psych-
otic” and “endogenous” depression had lower EDA
levels compared to “neurotic” and “non-endogenous”
depression. However, in view of the significant differ-
ences in the methodology and design of the relevant
studies and their inconsistent results, the utility of
EDA as a means of discrimination between subgroups
of depressive patients remains to be demonstrated.
Depressed patients vs. other psychiatric patients
Comparisons of EDA in depressed patients and pa-
tients with other psychiatric disorders have been per-
formed to ascertain whether EDA can be used as a
marker of depressive states.
EDA abnormalities have been described in schizo-
phrenic patients [64]. Compared with normal controls,
both schizophrenic and depressed patients showed high
levels of non-response in the habituation series, but
schizophrenics - unlike the depressed patients - showed
a decrease in SCR non-response to the target tone [55,
65]. In contrast Levinson [51] found no substantial dif-
ferences between schizophrenic and depressed patients
and normal controls with respect to SCR.
Pruneti et al. [66] found that patients with generalised
anxiety disorder or panic disorder had higher SCRs than
patients with major depression or obsessive-compulsive
disorder.
Have et al. [67] reported that depressed patients, pa-
tients with degenerative dementia of the Alzheimer type
and healthy controls had similar SCLs.
In summary, there have been only six studies comparing
depressed patients to other psychiatric patients, and they
deal with different disorders, making it hard to draw clear
conclusions.
Elicitation methods and EDA
The published research using emotional elicitation pro-
tocols and other tasks to investigate EDA is highly het-
erogeneous with respect to sample, EDA variables, task
Table 2 Summary of selected studies – Association between EDA and depression (Continued)
AUTHORS (COUNTRY
AND YEAR)
SUBJECTS (DIAGNOSIS; AGE;
MALE/FEMALE) AND CONTROLS
(MEAN AGE; MALE/FEMALE)
MEASURES MAIN STUDY FINDINGS STUDY
DESIGN
(QUALITY1)
Weckowicz et al (Alberta,
1971)
− 212 depressed inpatients included;
data at follow-up available for 170
(mean age 38 years; 69% females).
Galvanic skin responses
(GSR) to a noxious
stimulus, obtained one
minute after the last basal
reading.
Patients were tested after
admission and before
starting therapy. Second
assessment after 3 weeks
of therapy.
GSR was not a predictor
for ECT, it was a near-
significant predictor for
psychotherapy and for
drug therapy.
Cross-
Sectional
Williams et al.
(1985)
36 primary depressive patients:
− 27 unipolar (37.4±12.5 years; 74% females);
− 9 bipolar (46.2±10.1 years; 55% females).
SCL and SCR recorded for
two experimental
conditions:
− auditory stimuli during
relaxation;
− a task requiring
responding to specific
tones pressing a foot
pedal.
No differences in tonic or
phasic EDA in unipolar or
bipolar subtype, response
to the dexamethasone
suppression test, severity
of depression, medication
status, or gender.
Patients with psychomotor
retardation had
significantly lower levels of
tonic EDA than non-
retarded ones.
Cross-
sectional
Zullino et al.
(Switzerland, 2015)
− 58 patients randomly assigned
to 8-week Venlafaxine treatment
(44.9±8 years; 36.7% females) or
applied relaxation (45.6±11.3 years;
46.4% females).
Skin conductance. Patients treated with
Venlafaxine had
significantly lower EDA
than the other group,
both at week 4 and 8.
Randomized
comparative
Legend:
1The “Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control and cohort studies” was used to evaluate the case-control (scores 0-10) and cohort
studies (scores 0-12)
2Follow-up study of Iacono et al. (1983)
3Follow-up study of Thorell et al. 1987
CLBP= Chronic Low Back Pain; CS = Conditioned Stimuli; ECT=Electroconvulsive therapy; EDA = Electrodermal Activity; EDR = Electrodermal Response; GSC =
Galvanic skin conductance; GSR = Galvanic skin response; MDD = Major Depressive Disorder; MDE = Major Depressive Episode; NS.SCR = Nonspecific Skin
Conductance Response; OCD = Obsessive-Compulsive Disorder PTSD = Post-traumatic Stress Disorder; SAD = Seasonal Affective Disorder; SCL = Skin Conductance
Level; SCFr = Skin Conductance Fluctuation rate; SCR = Skin Conductance Response; SF= Spontaneous Fluctuation; SR = Skin Resistance; SRR = Skin Resistance
Response
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and NOS score (range: 3 - 6), making it very hard to
compare studies and to draw unequivocal conclusions.
Lower EDA, lower SCRs and higher SCL/SCRs were
found in depressed subjects compared with controls in
response to various emotional elicitation protocols
(including exposure to pleasant and unpleasant pic-
tures, exposure to sad and amusing film clips, and sup-
pression of emotional reaction to pictures) [68–71].
Other studies found contrasting or mixed results de-
pending on the type of task [72–75, 50]. For instance,
in a standardised mood induction experiment, MDD
patients had higher SCRs than controls in the cartoon
condition, but not when mood was induced through
happy and neutral pictures [73]. Schneider et al. [75]
found that depressed subjects showed increased re-
activity and autonomic arousal (elevated GSRs) in re-
sponse to affective stimuli, compared to healthy
controls [75]. Rohde and coworkers [76] studied de-
pressed patients and healthy controls performing a
Mindful Breathing Exercise task and found no difference
in SCR between the two groups.
A couple of studies including elicitation protocols
compared depressed patients with a seasonal pattern
(seasonal affective disorder) and healthy controls.
When exposed to overcast stimuli [77] or winter
scenes [78] patients with seasonal affective disorder
displayed more frequent SCRs and SCRs of greater
magnitude, whereas the opposite pattern was found
for sunny stimuli [77] and there was no disease by
stimulus interaction for SCLs [77].
In short, the heterogeneity of study designs does
not allow to draw clear conclusions in this field.
EDA and hormones
Only two studies dealt with this topic and they
concerned different hormones, so it is not possible to
generalise from the results. Based on the dexamethasone
suppression test EDA in depressive patients does not ap-
pear to be related to dysfunctions of the hypothalamic-
pituitary-adrenal axis. On the other hand, suicide
attempters exhibited opposite correlations between EDA
and cortisol in plasma and in urine, suggesting that there
may be a complex relationship between EDA and corti-
sol production [79].
The positive correlations found between basal levels of
thyroid hormones and SCL in healthy subjects were ab-
sent or reversed in depressed patients [80].
EDA and antidepressants
A cross-sectional study by Weckowicz [81] found GSR
was a near-significant predictor of psychotherapy and
drug therapy in depressed patients.
Several studies [37, 43, 55, 59, 82] failed to find any
difference in EDA levels in depressed patients in
response to antidepressant treatment or other medica-
tion, but it is hard to draw clear conclusions from
these studies, many of which assessed non-specified
antidepressants and/or antipsychotic medication.
Other studies investigating the effects of antidepres-
sant compounds on EDA have found different results,
but they cover a range of drugs and the results are
mixed. Of the studies selected for this review, 6
assessed the effects of tricyclic antidepressants (im-
ipramine [83, 84], amitriptyline [85–88]); 1 a tetracyc-
lic antidepressant (maprotiline; [83]); 1 a serotonin
antagonist and reuptake inhibitor (nefazodone; [89]);
3 selective serotonin reuptake inhibitors (paroxetine;
[84], sertraline; [90], fluoxetine; [91]); 1 a noradren-
aline reuptake inhibitor (reboxetine; [92]); 1 a
serotonin-noradrenaline reuptake inhibitor (venlafax-
ine; [93]); 1 a reversible inhibitor of monoamine oxi-
dase A (moclobemide; [94]); and 1 an unspecified
antidepressant [95].
Imipramine-treated patients showed lower EDA
than controls [84]. Regarding amitriptyline, findings
were not consistent across studies, spanning from no
correlation between the drug plasma level and EDA
measures [86], to lower activation and decreased
NS.SCRs and SCR in patients treated with amitriptyl-
ine [78, 87, 88]. Reboxetine reduced SCR after mul-
tiple dosing [92], while sertraline, moclobemide and
nefazodone-treated patients showed no change in SCR
[90, 94, 89]. On the other hand, sertraline-treated pa-
tients had lower SCL compared to controls [90]. Ven-
lafaxine caused a reduction of EDA measures [93].
See Tables 1 and 2 for further details.
Very briefly, studies of EDA and antidepressants, ei-
ther found no correlation between drugs and EDA
measures, or a reduction of EDA measures (NS.SCRs,
SCR, SCL) in subjects taking medications.
Other studies of EDA characteristics
A couple of follow-up studies investigated the temporal
stability of EDA. In the studies of Iacono and co-
workers [42, 45] the EDA variables were moderately
stable at the one-year follow-up, whereas in the study
of Thorell and d’Elia [43, 61] patients’ EDA was ele-
vated in the remission phase and similar to that of
the matched healthy subjects. It should be noted,
however, that the mean follow-up period in this study
was 2 years, which suggests that the recovery of tonic
EDA in patients with affective disorders is probably a
very slow process. Thorell and d’Elia’s study had a
more robust design than the Iacono studies (NOS 5
vs. NOS 3).
A one-year cross-sectional follow-up study of
depressive and depressive-anxious patients found
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mixed results with respect to the temporal stability of
EDA: changes were smallest in stable patients, and
greatest in all four labile-activated patients [85].
The laterality of EDA has also been explored and it
has been hypothesised that there is right-hemisphere
hyperexcitability in depressive conditions. After the
original 1978 study by Myslobodsky and Horesh [96]
others reported that EDA levels were lower on the
right hand than the left under various experimental
conditions, including rest [97]. Nevertheless, contrast-
ing results were obtained both at rest and during
stimulation [65, 98], and during different phases of
illness, including remission [37, 99]. Notably, the first
two studies cited in this paragraph had lower NOS
scores (3 and 2) than the last four (respectively 4, 6,
5, 5); the existence of lateral differences in EDA re-
mains to be confirmed.
EDA and suicidal behaviour
It has been suggested that differences in EDA may be
specific to suicidality rather than depression [100]. Al-
though there has been less research on EDA in indi-
viduals exhibiting suicidal behaviour than in people
with depression, there is consistent evidence of elec-
trodermal hypoactivity in depressed suicide attempters
compared with non-suicidal depressed patients and
healthy controls [61, 58, 101, 102].
Correlations between EDA and the type and level of sui-
cide risk have been suggested. For instance, one study
compared patients recently admitted to the hospital be-
cause of suicide threats or preoccupations, but with no
history of attempts, controls with no history of suicide
threats or attempts and no reported suicidal thoughts at
the time of data collection and suicide attempters with a
history of one or more suicide attempts. The first group
showed the smallest GSR to the word ‘suicide’, suggesting
generally lower reactivity [103].
Other studies have assessed SCR habituation in in-
dividuals with different patterns of suicidal behaviour.
Violent suicide attempters and suicide completers
were both found to be fast habituators [101, 104,
105]. The findings on non-violent suicide attempters,
patients with suicidal ideation and non-suicidal de-
pressed patients are less clear: one study found that
non-violent suicide attempters showed either fast or
slow habituation [101] but another found no differ-
ences among these groups (violent and non-violent
suicide attempters, patients with suicidal ideation,
non suicidal patients) [104]. Jandl et al. found no dif-
ference in the habituation of violent and non-violent
suicide attempters, but corroborated the general find-
ing of hyporeactivity in suicide attempters compared
with non-attempters [106]. A study comparing
parasuicidal adolescent girls with healthy controls
found no differences in EDA variables [107].
Thorell et al. [24] carried out a meta-analysis of
earlier research covering a total of 297 depressed pa-
tients and 59 healthy subjects. Electrodermal hypor-
eactivity was strongly associated with high suicide
risk. Extremely low electrodermal reactivity had a
sensitivity of 96.6% and a specificity of 92.9% for sui-
cide and a sensitivity of 83.3% and specificity of
92.7% for suicide and/or violent suicide attempt.
A further analysis of data from 783 depressive
patients by Thorell et al. [108] confirmed that electro-
dermal hyporeactivity is a marker of suicidal tendency
in both unipolar and bipolar depression, independ-
ently of severity of depression, trait anxiety, gender
and age.
Recently the protocol for a study involving 1573
patients with a primary diagnosis of depression
recruited from 15 centres in nine European countries
that will test the predictive value of electrodermal
hyporeactivity (measured with the electrodermal
orienting reactivity EDOR test) for suicide and suicide
attempt has been published. The extant literature sug-
gests that suicide attempt with intent to die and com-
pleted suicide will be associated with electrodermal
hyporeactivity [27].
Discussion
The aim of this review is to offer a comprehensive
overview of the EDA literature with a view to
assessing its potential utility as a biomarker of
depressive states and risk of suicidal behaviour, and
its potential role in advanced, integrated physiological
evaluation systems.
Overall, our review of the literature supports the
hypothesis that electrodermal hypoactivity is a feature
of depression. Nevertheless, considering the number
and robustness of studies, EDA seems to be more
useful in discriminating depressive patients from
healthy controls than from other psychiatric patients.
Moreover, specific EDA features (e.g., SCL, SCR,
NS.SCR, habituation rate, etc.) seem to be differently
affected, and the extremely contrasting nature of
studies and of the variables used cannot be over-
looked. Briefly, specific patterns of electrodermal
hypoactivity may be a reliable marker of a depressive
state at population level, but they should be carefully
combined with other physiological and non-
physiological indicators when used for preventive and
diagnostic purposes.
Another area that deserves further investigation is the
potential use of EDA to distinguish between subtypes
of depression. At present the evidence suggests that pa-
tients with psychomotor retardation, endogenous and
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psychotic depression show lower EDA values than pa-
tients with agitation, non-endogenous and neurotic de-
pression, respectively.
It has been hypothesised that electrodermal hypoac-
tivity is a rather stable trait of patients affected by
depression, although increases in EDA may indicate
euthymia or remission [61, 54]. It should be noted
that extremely hyporesponsive depressive patients, in-
cluding suicide attempters and patients with recur-
rent major depression, may fail to reach the EDA
levels of healthy subjects even when in remission
[54].
There is even more debate about the effects of
antidepressants on EDA and research has yielded
mixed results. In the context of experimental
anxiety conditioning tasks some antidepressants
blunt EDA in healthy subjects, but the data from
depressed patients are not consistent and there is
no clear correlation between EDA and clinical
improvement. As Thorell hypothesised, electroder-
mal hypoactivity may be a rather stable trait of
depressed patients; EDA appears to be only margin-
ally affected by treatment and clinical improvement,
and normalisation may not occur until several
months - or even years - after clinical recovery
[61]. Moreover, there is only limited evidence in re-
lation to each drug and for most drugs it comes
from just one study.
As far as suicidal behaviour is concerned, extreme
hyporeactivity has been consistently reported in
both suicide attempters and at baseline in subjects
who eventually committed suicide during a follow-
up period; moreover, hyporeactivity seems to be
related to the choice of a violent method for
attempted or completed suicide [101, 104, 105]. On
this basis it has been hypothesised that extreme
electrodermal hypoactivity is a marker of suicidal
tendencies in depressed patients, and it appears to
be independent of severity of depression [61, 102].
Recent studies [24, 108] showed that EDA discrimi-
nates well between patients who will subsequently
commit suicide, make a non-violent suicide attempt
or make a violent suicide attempt, but it is less
clear that EDA can be used to distinguish individ-
uals with current suicidal ideation from depressed
patients who are not currently suicidal. Neverthe-
less, it has been suggested that the evidence is suf-
ficient to warrant strict monitoring of both
euthymic and depressed patients who are show
extreme electrodermal hyporeactivity, even in the
absence of suicidal ideation. Obviously close moni-
toring and adequate antidepressant therapy are even
more necessary in hyporeactive patients with sui-
cidal ideation [24].
Assessment of the robustness of the synthesis and
limitations
We adhered to the PRISMA statement [28, 29], which
requires the use of defined inclusion/exclusion cri-
teria, a rigorous search strategy and assessment of the
quality assessment of included studies. Nevertheless,
several limitations of this review should be
acknowledged. First, as shown by the NOS scores, the
quality of several of the included studies is
questionable and most are quite old. The criteria for
‘depression’ vary somewhat between studies. Most of
studies used the Diagnostic and Statistical Manual of
Mental Disorders (DSM-III and DSM-IV) criteria
[109, 110], but some used the International Classifica-
tion of Diseases (ICD-9 and ICD-10) [111, 112], the
Research Diagnostic Criteria [113], the Feighner Re-
search Criteria or multiple classification systems
[114]. Definitional inconsistency is also a problem in
comparisons of subtypes of depression as there are
no standard criteria for distinguishing between, for
example, retarded and agitated depression, endogen-
ous and non-endogenous depression or psychotic and
neurotic depression. Furthermore, most studies in-
cluded patients with various mood disorder diagnoses
(e.g., unipolar depression, bipolar depression, dys-
thymia), without specifying the illness phase or the
treatment patients were receiving. Finally, comorbidity
was not always accounted for in comparisons between
depression and other pathological conditions.
Besides diagnostic issues, over time the EDA
assessment methods have changed, leading to
inconsistencies. Not all the studies have assessed the
same EDA parameters, and despite improvements in
measuring equipment since the discovery of electro-
dermal phenomena more than 100 years ago [32],
much of the research reviewed in the present article
is limited to observational measurements performed
over short periods of time, in laboratory settings or
artificial clinical environments.
Conclusions
This review offers a more comprehensive assessment
of the extant EDA literature than previous ones [25,
26] and it corroborates their findings, namely that
there are associations between electrodermal hypoac-
tivity and depression and suicidal behaviour. EDA ap-
pears to be a reliable marker, with high sensitivity
and specificity, of depressive states, suicidal tenden-
cies and suicidal behaviour [24, 39, 43, 108]. Never-
theless, further studies are required to validate EDA
as an indicator of other clinical features, such as de-
pression subtypes, response to treatment and acute
suicide risk.
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EDA: Electrodermal activity; GSR: Galvanic skin response; MDD: Major
depressive disorder; NS.SCR: Non-specific skin conductance response;
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SCL: Skin conductance level; SCR: Skin conductance response; SRR: Skin
resistance response
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